NL-OMON55433招募中4 期
Effect of Reslizumab on small airways in asthma. RESSAPEA - RESSAPEA
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •severe asthma; Blood eosinophil counts >=0.4 x 10E9/L despite adequate
- •treatment with high doses of inhaled corticosteroids (>1000mcg/day fluticasone
- •equivalent)
排除标准
- •Subjects with other conditions that could lead to elevated eosinophils such as
- •Hyper eosinophilic Syndromes, including Churg-Strauss Syndrome, or Eosinophilic
- •Esophagitis.
- •malignancies; use of other monoclonals (except omalizumab)
研究者
相似试验
进行中（未招募）
1 期
Effect of Reslizumab on small airways in asthma. RESSAPEA1.Patients with severe eosinophilic asthmaMedDRA version: 20.0Level: LLTClassification code 10068462Term: Eosinophilic asthmaSystem Organ Class: 100000004855EUCTR2017-003958-16-NLAcademic Medical Center, University of Amsterdam33
尚未招募
不适用
Effect of Reslizumab on small airways in asthma - RESSAPEANL-OMON29078Amsterdam University Medical Centre, University of Amsterdam33
进行中（未招募）
1 期
TARGETTargeting the small airways in asthma”MedDRA version: 17.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-001143-31-DKBispebjerg University Hospital40
尚未招募
不适用
An exploratory study to assess the effect of benralizumab on small airway obstruction in patients with severe asthma using functional respiratory imagingasthmaNL-OMON26915Ciro20
进行中（未招募）
1 期
Reslizumab in patients with severe asthma who failed to respond to omalizumabSevere asthmaMedDRA version: 19.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2016-004459-65-ESRespira. Fundación Española del Pulmón (SEPAR)